Andrew Murphy - Dec 4, 2023 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Signature
/s/**Andrew Murphy
Stock symbol
REGN
Transactions as of
Dec 4, 2023
Transactions value $
-$10,888,229
Form type
4
Date filed
12/6/2023, 04:02 PM
Previous filing
Nov 15, 2023
Next filing
Dec 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $5.41M +20K +33.66% $270.43 79.4K Dec 4, 2023 Direct F1
transaction REGN Common Stock Tax liability -$11M -13.5K -16.95% $813.58 66K Dec 4, 2023 Direct F1
transaction REGN Common Stock Sale -$110K -136 -0.21% $810.38 65.8K Dec 5, 2023 Direct F1
transaction REGN Common Stock Sale -$83.6K -103 -0.16% $811.37 65.7K Dec 5, 2023 Direct F1
transaction REGN Common Stock Sale -$302K -372 -0.57% $812.57 65.3K Dec 5, 2023 Direct F1, F2
transaction REGN Common Stock Sale -$136K -167 -0.26% $813.66 65.2K Dec 5, 2023 Direct F1, F3
transaction REGN Common Stock Sale -$47.2K -58 -0.09% $814.06 65.1K Dec 5, 2023 Direct F1
transaction REGN Common Stock Sale -$126K -155 -0.24% $815.97 65K Dec 5, 2023 Direct F1, F4
transaction REGN Common Stock Sale -$677K -829 -1.28% $816.46 64.1K Dec 5, 2023 Direct F1, F5
transaction REGN Common Stock Sale -$1.54M -1.88K -2.93% $817.36 62.3K Dec 5, 2023 Direct F1, F6
transaction REGN Common Stock Sale -$1.09M -1.33K -2.14% $818.59 60.9K Dec 5, 2023 Direct F1, F7
transaction REGN Common Stock Sale -$797K -973 -1.6% $819.57 60K Dec 5, 2023 Direct F1, F8
transaction REGN Common Stock Sale -$283K -345 -0.58% $820.54 59.6K Dec 5, 2023 Direct F1, F9
transaction REGN Common Stock Sale -$151K -184 -0.31% $821.46 59.4K Dec 5, 2023 Direct F1, F10
holding REGN Common Stock 4.31K Dec 4, 2023 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -20K -100% $0.00* 0 Dec 4, 2023 Common Stock 20K $270.43 Direct F1, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on May 9, 2023.
F2 Represents volume-weighted average price of sales of 372 shares of Company stock on December 5, 2023 at prices ranging from $812.26 to $812.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 5, 2023 at each separate price.
F3 Represents volume-weighted average price of sales of 167 shares of Company stock on December 5, 2023 at prices ranging from $813.00 to $813.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 5, 2023 at each separate price.
F4 Represents volume-weighted average price of sales of 155 shares of Company stock on December 5, 2023 at prices ranging from $815.90 to $815.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 5, 2023 at each separate price.
F5 Represents volume-weighted average price of sales of 829 shares of Company stock on December 5, 2023 at prices ranging from $816.01 to $816.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 5, 2023 at each separate price.
F6 Represents volume-weighted average price of sales of 1,881 shares of Company stock on December 5, 2023 at prices ranging from $817.04 to $817.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 5, 2023 at each separate price.
F7 Represents volume-weighted average price of sales of 1,333 shares of Company stock on December 5, 2023 at prices ranging from $818.07 to $818.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 5, 2023 at each separate price.
F8 Represents volume-weighted average price of sales of 973 shares of Company stock on December 5, 2023 at prices ranging from $819.03 to $819.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 5, 2023 at each separate price.
F9 Represents volume-weighted average price of sales of 345 shares of Company stock on December 5, 2023 at prices ranging from $820.27 to $820.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 5, 2023 at each separate price.
F10 Represents volume-weighted average price of sales of 184 shares of Company stock on December 5, 2023 at prices ranging from $821.39 to $821.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 5, 2023 at each separate price.
F11 The stock option award vests in four equal annual installments, commencing one year after the date of grant.